GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InnoCare Pharma Ltd (FRA:33C) » Definitions » Other Gross PPE

InnoCare Pharma (FRA:33C) Other Gross PPE : €80.5 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is InnoCare Pharma Other Gross PPE?

InnoCare Pharma's Other Gross PPE for the quarter that ended in Sep. 2024 was €80.5 Mil.

InnoCare Pharma's quarterly Other Gross PPE increased from Mar. 2024 (€80.1 Mil) to Jun. 2024 (€141.1 Mil) but then declined from Jun. 2024 (€141.1 Mil) to Sep. 2024 (€80.5 Mil).

InnoCare Pharma's annual Other Gross PPE increased from Dec. 2021 (€1.1 Mil) to Dec. 2022 (€1.3 Mil) and increased from Dec. 2022 (€1.3 Mil) to Dec. 2023 (€1.5 Mil).


InnoCare Pharma Other Gross PPE Historical Data

The historical data trend for InnoCare Pharma's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnoCare Pharma Other Gross PPE Chart

InnoCare Pharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial 0.45 1.11 1.35 1.50 139.84

InnoCare Pharma Quarterly Data
Dec17 Dec18 Sep19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.50 80.15 141.08 80.48 139.84

InnoCare Pharma Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


InnoCare Pharma Business Description

Traded in Other Exchanges
Address
No. 8 Life Science Park Road, Building 8, Zhongguancun Life Science Park, Changping District, Beijing, CHN, 102206
InnoCare Pharma Ltd is a commercial-stage biopharmaceutical company. It discovers, develops, and commercializes drugs for the treatment of cancer and autoimmune diseases. The company's main product pipeline includes orelabrutinib, ibrutinib, zanubrutinib, tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-192, ICP-723, and ICP-189, among others. Its products are mainly used to treat hematological tumors, solid tumors, and autoimmune diseases. The company is also developing products for the treatment of autoimmune diseases caused by abnormal B-cell or T-cell function.

InnoCare Pharma Headlines

No Headlines